Literature DB >> 22489591

Psychosis induced by the interaction between disulfiram and methylphenidate may be dose dependent.

Lara Grau-López1, Carlos Roncero, Maria C Navarro, Miquel Casas.   

Abstract

There are few studies describing psychiatric symptoms occurring when methylphenidate and disulfiram are used together. The authors report a case of disulfiram and methylphenidate interaction in which psychotic symptoms could be dose dependent. The patient, diagnosed of alcohol and cocaine dependence and attention deficit hyperactivity disorder (ADHD), started treatment with methylphenidate increasing doses and disulfiram 250 mg/day over 4 weeks. During the first 2 weeks at doses of 36 mg/day of methylphenidate and maintaining disulfiram, side effects were not observed. However, by increasing to 54 mg/day, psychotic symptoms were detected. The authors reported that the effects are dose dependent. This is the first report about dose-dependent side effects in substance use disorder with ADHD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489591     DOI: 10.1080/08897077.2011.634968

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  5 in total

1.  International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Authors:  Cleo L Crunelle; Wim van den Brink; Franz Moggi; Maija Konstenius; Johan Franck; Frances R Levin; Geurt van de Glind; Zsolt Demetrovics; Corné Coetzee; Mathias Luderer; Arnt Schellekens; Frieda Matthys
Journal:  Eur Addict Res       Date:  2018-03-06       Impact factor: 3.015

2.  Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.

Authors:  Avanti Gokhale; Alysia Vrailas-Mortimer; Jennifer Larimore; Heather S Comstra; Stephanie A Zlatic; Erica Werner; Daniel F Manvich; P Michael Iuvone; David Weinshenker; Victor Faundez
Journal:  Hum Mol Genet       Date:  2015-07-21       Impact factor: 6.150

3.  Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.

Authors:  Paola Devoto; Giovanna Flore; Pierluigi Saba; Roberto Frau; Gian L Gessa
Journal:  Brain Behav       Date:  2015-09-24       Impact factor: 2.708

4.  Does amantadine induce acute psychosis? A case report and literature review.

Authors:  Wei-Juan Xu; Ning Wei; Yi Xu; Shao-Hua Hu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-06       Impact factor: 2.570

Review 5.  Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse.

Authors:  Carlos Roncero; Alfonso C Abad; Antonio Padilla-Mata; Elena Ros-Cucurull; Carmen Barral; Miquel Casas; Lara Grau-López
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.